InsiderTrades.com logo

RARE Insider Trading

Insider Ownership Percentage: 5.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,954,255.11

Ultragenyx Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at Ultragenyx Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ultragenyx Pharmaceutical Share Price & Price History

Current Price: $19.87
Price Change: ▼ Price Decrease of -0.55 (-2.69%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for RARE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ultragenyx Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/3/2026Howard HornCFOSell1,635$22.40$36,624.0085,034View SEC Filing Icon  
3/2/2026Emil D KakkisCEOSell54,404$22.80$1,240,411.20658,994View SEC Filing Icon  
3/2/2026Eric CrombezEVPSell7,029$22.80$160,261.2076,301View SEC Filing Icon  
3/2/2026Erik HarrisEVPSell10,539$22.80$240,289.2089,515View SEC Filing Icon  
3/2/2026Howard HornCFOSell8,409$22.70$190,884.3086,669View SEC Filing Icon  
3/2/2026John Richard PinionInsiderSell10,029$22.80$228,661.20110,026View SEC Filing Icon  
3/2/2026Karah Herdman ParschauerEVPSell8,135$22.80$185,478.0076,346View SEC Filing Icon  
3/2/2026Theodore Alan HuizengaCAOSell1,632$22.80$37,209.6048,670View SEC Filing Icon  
2/2/2026Howard HornCFOSell3,061$23.56$72,117.1688,935View SEC Filing Icon  
12/29/2025Theodore Alan HuizengaCAOSell85$34.38$2,922.3050,450View SEC Filing Icon  
12/10/2025Howard HornCFOSell3,081$36.38$112,086.7895,146View SEC Filing Icon  
10/13/2025Howard HornCFOSell7,942$31.51$250,252.4298,227View SEC Filing Icon  
9/18/2025Theodore Alan HuizengaCAOSell64$29.17$1,866.8850,242View SEC Filing Icon  
9/12/2025Karah Herdman ParschauerEVPSell2,450$31.17$76,366.5073,271View SEC Filing Icon  
6/20/2025Corsee D. SandersDirectorSell2,405$37.39$89,922.9515,344View SEC Filing Icon  
5/5/2025Eric CrombezEVPSell520$39.24$20,404.8071,530View SEC Filing Icon  
4/21/2025Eric CrombezEVPSell242$35.11$8,496.6271,680View SEC Filing Icon  
3/6/2025Howard HornCFOSell1,785$40.40$72,114.00106,169View SEC Filing Icon  
3/3/2025Emil D KakkisCEOSell73,434$42.10$3,091,571.40641,731View SEC Filing Icon  
3/3/2025John Richard PinionInsiderSell14,439$42.10$607,881.90107,766View SEC Filing Icon  
3/3/2025Theodore Alan HuizengaCAOSell967$42.10$40,710.7050,265View SEC Filing Icon  
3/3/2025Thomas Richard KassbergEVPSell6,028$42.10$253,778.80265,238View SEC Filing Icon  
2/28/2025Emil D KakkisCEOSell25,000$42.48$1,062,000.002,158,985View SEC Filing Icon  
2/27/2025Karah Herdman ParschauerEVPSell2,990$42.88$128,211.2054,991View SEC Filing Icon  
12/30/2024Emil D KakkisCEOSell11,727$42.23$495,231.212,183,985View SEC Filing Icon  
12/10/2024Emil D KakkisCEOSell8,273$50.00$413,650.002,195,712View SEC Filing Icon  
10/10/2024Howard HornCFOSell7,465$52.76$393,853.4092,301View SEC Filing Icon  
9/3/2024Emil D KakkisCEOSell20,000$55.85$1,117,000.002,223,985View SEC Filing Icon  
9/3/2024Theodore Alan HuizengaCAOSell91$56.19$5,113.2941,551View SEC Filing Icon  
8/6/2024Emil D KakkisCEOSell20,000$50.17$1,003,400.002,243,985View SEC Filing Icon  
7/2/2024Corsee D. SandersDirectorSell584$40.98$23,932.3212,009View SEC Filing Icon  
6/12/2024Karah Herdman ParschauerEVPSell9,806$45.00$441,270.0057,981View SEC Filing Icon  
6/10/2024Corsee D. SandersDirectorSell1,737$41.10$71,390.707,248View SEC Filing Icon  
4/18/2024Eric CrombezEVPSell142$44.10$6,262.2048,785View SEC Filing Icon  
3/11/2024Thomas Richard KassbergEVPSell11,509$49.93$574,644.37252,823View SEC Filing Icon  
3/7/2024Matthew K. FustDirectorSell12,195$50.88$620,481.6014,860View SEC Filing Icon  
3/1/2024John Richard PinionInsiderSell4,173$53.76$224,340.4889,268View SEC Filing Icon  
3/1/2024Karah Herdman ParschauerEVPSell3,756$53.76$201,922.5667,340View SEC Filing Icon  
3/1/2024Theodore Alan HuizengaCAOSell341$53.76$18,332.1641,380View SEC Filing Icon  
10/23/2023Thomas Richard KassbergEVPSell39,878$32.78$1,307,200.84246,860View SEC Filing Icon  
10/19/2023Emil D KakkisCEOSell47,853$33.52$1,604,032.56599,743View SEC Filing Icon  
9/7/2023Theodore Alan HuizengaCAOSell2,163$40.80$88,250.4023,614View SEC Filing Icon  
9/5/2023Erik HarrisEVPSell6,000$37.96$227,760.0051,281View SEC Filing Icon  
9/1/2023Theodore Alan HuizengaCAOSell970$37.15$36,035.5023,777View SEC Filing Icon  
6/30/2023Corsee D. SandersDirectorSell585$46.76$27,354.608,985View SEC Filing Icon  
6/19/2023Erik HarrisEVPSell305$48.20$14,701.0057,281View SEC Filing Icon  
6/8/2023Corsee D. SandersDirectorSell1,485$51.65$76,700.259,570View SEC Filing Icon  
5/18/2023John Richard PinionInsiderSell2,012$50.00$100,600.0074,744View SEC Filing Icon  
5/4/2023Karah Herdman ParschauerEVPSell4,378$45.00$197,010.0051,982View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ultragenyx Pharmaceutical (NASDAQ:RARE)

97.67% of Ultragenyx Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RARE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ultragenyx Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC29,679$0.66M0.0%-61.4%0.031%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.7,716$0.18M0.0%+611.8%0.008%Search for SEC Filing on Google Icon
3/9/2026Flax Pond Capital LLC56,238$1.29M1.0%N/A0.058%Search for SEC Filing on Google Icon
3/3/2026Caitong International Asset Management Co. Ltd122,854$2.83M0.7%+1,116,754.5%0.127%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.230,271$5.30M0.0%-71.0%0.239%Search for SEC Filing on Google Icon
2/19/2026Alberta Investment Management Corp38,400$0.88M0.0%N/A0.040%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV13,965$0.32M0.0%+17.1%0.014%Search for SEC Filing on Google Icon
2/18/2026Krensavage Asset Management LLC149,634$3.44M1.2%N/A0.155%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC2,877$66K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd119,996$2.76M0.1%+734.8%0.124%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC643,356$14.80M0.1%+33.3%0.667%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC18,862$0.43M0.1%+66.8%0.020%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP2,461,910$56.62M0.0%+26.6%2.552%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL13,416$0.31M0.0%-84.4%0.014%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP100,152$2.30M0.2%N/A0.104%Search for SEC Filing on Google Icon
2/18/2026Superstring Capital Management LP31,738$0.73M0.4%N/A0.033%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd66,001$1.52M0.0%N/A0.068%Search for SEC Filing on Google Icon
2/18/2026RTW Investments LP3,000,139$69M0.7%-7.9%3.110%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP20,475$0.47M0.2%N/A0.021%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC22,230$0.51M0.4%N/A0.023%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC880,644$20.26M0.0%+787.6%0.913%Search for SEC Filing on Google Icon
2/18/2026Man Group plc78,371$1.80M0.0%+995.8%0.081%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP50,000$1.15M1.3%N/A0.052%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP76,702$1.76M0.0%+131.6%0.080%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP317,182$7.30M0.4%N/A0.329%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP162,550$3.74M0.7%-44.2%0.168%Search for SEC Filing on Google Icon
2/18/2026683 Capital Management LLC222,395$5.12M0.2%+109.8%0.231%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC49,137$1.13M0.0%+4.4%0.051%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC176,813$4.07M0.3%+12.8%0.183%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC1,360,497$31.29M0.0%+82.3%1.410%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP165,017$3.80M0.0%+6.2%0.171%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC115,928$2.67M0.0%+101.7%0.120%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,554,366$35.75M0.0%-32.7%1.611%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP1,267,241$29.15M1.5%+1.7%1.313%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.280,000$6.44M0.0%-34.9%0.290%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System83,337$1.92M0.0%+3.0%0.086%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board58,657$1.35M0.0%-27.5%0.061%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors11,378$0.26M0.0%+26.1%0.012%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC411,863$9.47M0.0%-8.2%0.427%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP137,392$3.16M0.0%+28.9%0.142%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada163,227$3.75M0.0%-30.9%0.169%Search for SEC Filing on Google Icon
2/17/2026Polar Capital Holdings Plc556,628$12.80M0.0%-4.6%0.577%Search for SEC Filing on Google Icon
2/17/2026Aster Capital Management DIFC Ltd2,443$56K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Alberta Investment Management Corp38,400$0.88M0.0%N/A0.040%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC390,599$8.98M0.0%+192.0%0.405%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.83,300$1.92M0.1%N/A0.086%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC282,376$6.50M0.0%+1,100.6%0.293%Search for SEC Filing on Google Icon
2/16/2026Sands Capital Management LLC3,485,724$80.17M0.2%-7.5%3.613%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC10,245$0.24M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP60,641$1.40M0.1%+202.2%0.063%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP72,168$1.66M0.0%-50.6%0.075%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 331,169$7.61M0.0%-4.0%0.343%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co10,623$0.25M0.0%-60.6%0.011%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC75,000$1.73M0.1%N/A0.078%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp18,997$0.44M0.0%-25.4%0.020%Search for SEC Filing on Google Icon
2/13/2026Quarry LP5,000$0.12M0.0%+4,445.5%0.005%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC2,489$57K0.0%+43.2%0.003%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group175,635$4M0.0%+16.6%0.182%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.1,749,268$40.23M0.2%-19.3%1.813%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC157,061$3.61M0.0%+0.4%0.163%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP16,642$0.38M0.0%-54.2%0.017%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC28,207$0.65M0.1%+10.9%0.029%Search for SEC Filing on Google Icon
2/13/2026Birchview Capital LP62,000$1.43M0.8%+181.8%0.064%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.598,924$13.78M0.0%-0.2%0.621%Search for SEC Filing on Google Icon
2/13/2026Van ECK Associates Corp5,167$0.12M0.0%+95.0%0.005%Search for SEC Filing on Google Icon
2/13/2026State Street Corp4,303,046$98.97M0.0%+16.5%4.460%Search for SEC Filing on Google Icon
2/13/2026Caitong International Asset Management Co. Ltd7,611$0.18M0.5%+69,090.9%0.008%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC204,107$4.69M0.0%-1.4%0.212%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN63,563$1.46M0.0%+154.8%0.066%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP501,679$11.54M0.0%N/A0.520%Search for SEC Filing on Google Icon
2/12/2026SR One Capital Management LP137,753$3.17M0.4%N/A0.143%Search for SEC Filing on Google Icon
2/12/2026State Board of Administration of Florida Retirement System96,836$2.23M0.0%+4.4%0.100%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC366,100$8.42M0.0%+1,571.7%0.379%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc250,571$5.76M0.0%+41.2%0.260%Search for SEC Filing on Google Icon
2/12/2026Marex Group plc9,658$0.22M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund34,024$0.78M0.0%-3.7%0.035%Search for SEC Filing on Google Icon
2/12/2026Knott David M Jr20,006$0.46M0.2%-61.5%0.021%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank171,052$3.93M0.0%+3.7%0.177%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC801,473$18.43M0.0%+17.5%0.831%Search for SEC Filing on Google Icon
2/12/2026Xponance LLC14,390$0.33M0.0%+6.6%0.015%Search for SEC Filing on Google Icon
2/11/2026Empowered Funds LLC2,877$66K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/11/2026Inceptionr LLC19,714$0.45M0.1%N/A0.020%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG599,473$13.79M0.0%-61.2%0.621%Search for SEC Filing on Google Icon
2/11/2026GW&K Investment Management LLC1,375,407$31.63M0.3%+19.6%1.426%Search for SEC Filing on Google Icon
2/11/2026Motley Fool Wealth Management LLC297,486$6.84M0.5%-16.3%0.308%Search for SEC Filing on Google Icon
2/11/2026Motley Fool Asset Management LLC72,448$1.67M0.1%-12.3%0.075%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC15,678$0.36M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.309,062$7.11M0.0%-54.4%0.320%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC134,467$3.09M0.0%-31.0%0.139%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc81,964$1.89M0.0%-15.5%0.085%Search for SEC Filing on Google Icon
2/10/2026Natixis Advisors LLC21,077$0.49M0.0%+7.7%0.022%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets903,050$20.77M0.0%+57.6%0.936%Search for SEC Filing on Google Icon
2/10/2026Norges Bank1,261,026$29M0.0%N/A1.307%Search for SEC Filing on Google Icon
2/10/2026SBI Okasan Asset Management Co.Ltd.14,400$0.33M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,838,208$42.29M0.0%+16.3%1.905%Search for SEC Filing on Google Icon
2/9/2026Fisher Asset Management LLC198,696$4.57M0.0%+18.2%0.206%Search for SEC Filing on Google Icon
2/9/2026Blue Owl Capital Holdings LP212,638$4.89M0.4%-49.7%0.220%Search for SEC Filing on Google Icon
2/9/2026Legal & General Group Plc411,273$9.46M0.0%+2.1%0.426%Search for SEC Filing on Google Icon
2/9/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.61,329$1.41M0.1%N/A0.064%Search for SEC Filing on Google Icon
2/9/2026Jefferies Financial Group Inc.477,092$10.97M0.1%N/A0.494%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Japan, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; University of Pennsylvania; Arcturus Therapeutics Holdings Inc.; Solid Biosciences Inc.; Regeneron; Abeona; and Daiichi Sankyo Co., Ltd. The company was incorporated in 2010 and is headquartered in Novato, California.
Read More on Ultragenyx Pharmaceutical

Today's Range

Now: $19.87
Low: $19.86
High: $20.68

50 Day Range

MA: $22.78
Low: $19.87
High: $24.80

52 Week Range

Now: $19.87
Low: $18.41
High: $42.37

Volume

3,797,444 shs

Average Volume

1,884,919 shs

Market Capitalization

$1.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Who are the company insiders with the largest holdings of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top insider shareholders include:
  1. Emil D Kakkis (CEO)
  2. Thomas Richard Kassberg (EVP)
  3. John Richard Pinion (Insider)
  4. Howard Horn (CFO)
  5. Erik Harris (EVP)
  6. Karah Herdman Parschauer (EVP)
  7. Eric Crombez (EVP)
  8. Theodore Alan Huizenga (CAO)
  9. Corazon (Corsee) D Sanders (Director)
Learn More about top insider investors at Ultragenyx Pharmaceutical.

Who are the major institutional investors of Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical's top institutional investors include:
  1. Vanguard Group Inc. — 10.64%
  2. State Street Corp — 4.46%
  3. Sands Capital Management LLC — 3.61%
  4. RTW Investments LP — 3.11%
  5. Wellington Management Group LLP — 2.55%
  6. Geode Capital Management LLC — 1.91%
Learn More about top institutional investors of Ultragenyx Pharmaceutical stock.

Which major investors are selling Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was sold by these institutional investors:
  1. Deutsche Bank AG
  2. Price T Rowe Associates Inc. MD
  3. Invesco Ltd.
  4. Jacobs Levy Equity Management Inc.
  5. Franklin Resources Inc.
  6. Sands Capital Management LLC
  7. RTW Investments LP
  8. Pictet Asset Management Holding SA
During the previous year, company insiders that have sold Ultragenyx Pharmaceutical company stock include:
  1. Emil D Kakkis (CEO)
  2. Thomas Richard Kassberg (EVP)
  3. John Richard Pinion (Insider)
  4. Howard Horn (CFO)
  5. Erik Harris (EVP)
  6. Karah Herdman Parschauer (EVP)
  7. Eric Crombez (EVP)
  8. Theodore Alan Huizenga (CAO)
Learn More investors selling Ultragenyx Pharmaceutical stock.

Which major investors are buying Ultragenyx Pharmaceutical stock?

During the last quarter, RARE stock was purchased by institutional investors including:
  1. Norges Bank
  2. Millennium Management LLC
  3. AQR Capital Management LLC
  4. State Street Corp
  5. Wellington Management Group LLP
  6. HRT Financial LP
  7. Aberdeen Group plc
  8. Jefferies Financial Group Inc.